Showing results (1111-1120 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 17, 2010
Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivoSun-Young Han, Chong Ock Lee, Sung-Hoon Ahn, et al.
Investigational New Drugs|November 17, 2010
Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancerLixin Ma, Haiquan Qiao, Changjun He, et al.
Investigational New Drugs|September 30, 2010
Treatment of bevacizumab-induced hypertension by amlodipineOlivier Mir, Romain Coriat, Stanislas Ropert, et al.
Investigational New Drugs|November 1, 1990
Evaluation of a platinum-doxorubicin complex in experimental tumor systemsF Zunino, G Pratesi, F Formelli, et al.
Investigational New Drugs|November 1, 1990
Fluorinated anthracyclines: interactions with DNAK C Tonkin, R C Boston, R T Brownlee, et al.
Investigational New Drugs|November 1, 1990
Phase II trial of echinomycin in advanced soft tissue sarcomas. A Southwest Oncology Group studyS A Taylor, B Metch, S P Balcerzak, et al.
Investigational New Drugs|September 10, 2010
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenograftsPaola Secchiero, Federica Corallini, Barbara Zavan, et al.
Investigational New Drugs|September 11, 2010
Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II studyKatalin Boér, István Láng, Antonio Llombart-Cussac, et al.
Investigational New Drugs|October 28, 2010
Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)Yevgeniy Balagula, Katherine Barth Huston, Klaus J Busam, et al.
Investigational New Drugs|September 3, 2010
Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinomaPo Yen Liu, Jim Jinn-Chyuan Sheu, Po Cheng Lin, et al.
Pageof 372